Article

Antinociception induced by acute oral administration of sweet substance in young and adult rodents: the role of endogenous opioid peptides chemical mediators and μ(1)-opioid receptors.

Laboratório de Neuroanatomia & Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Av. dos Bandeirantes, 3900, 14049-900, Ribeirão Preto (SP), Brazil.
Pharmacology Biochemistry and Behavior (Impact Factor: 2.82). 12/2011; 101(2):265-70. DOI: 10.1016/j.pbb.2011.12.005
Source: PubMed

ABSTRACT The present work aimed to investigate the effects of acute sucrose treatment on the perception of painful stimuli. Specifically, we sought to determine the involvement of the endogenous opioid peptide-mediated system as well as the role of the μ(1)-opioid receptor in antinociception organisation induced by acute sucrose intake. Nociception was assessed with the tail-flick test in rats (75, 150 and 250 g) of different ages acutely pre-treated with 500 μL of a sucrose solution (25, 50, 150 and 250 g/L) or tap water. Young and Adult rats (250 g) showed antinociception after treatment with 50 g/L (during 5 min) and 150 g/L and 250 g/L (during 20 min) sucrose solutions. Surprisingly, this antinociception was more consistent in mature adult rodents than in pups. To evaluate the role of opioid systems, mature adult rodents were pre-treated with different doses (0.25, 1 or 4 mg/kg) of the non-selective opioid receptor antagonist naloxone, the selective μ(1)-opioid receptor antagonist naloxonazine or vehicle followed by 250 g/L sucrose solution treatment. Sucrose-induced antinociception was reduced by pre-treatment with both naloxone and naloxonazine. The present findings suggest that sweet substance-induced hypo-analgesia is augmented by increasing sucrose concentrations in young and adult rodents. Acute oral sucrose treatment inhibits pain in laboratory animal by mediating endogenous opioid peptide and μ(1)-opioid receptor actions.

0 Bookmarks
 · 
72 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper is the thirty-fifth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2012 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17).
    Peptides 10/2013; · 2.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ostracism causes social pain and is known to activate regions of the brain that are involved in the representation of physical pain. Previous research has observed that acetominophen (a common pain reliever) can reduce the pain of exclusion. The taste and consumption of glucose can also relieve physical pain, and the purpose of the current study was to examine whether it might also reduce the negative emotional effects of ostracism. In an appropriately powered experiment, participants were given 25g of glucose or a sucralose placebo before being ostracized while playing Cyberball. Strong effects of ostracism were observed, however, there was no effect of glucose on immediate or delayed self-reported needs or mood. These results are discussed in reference to the possibility that social pain is unlike physical pain since the latter is affected by glucose, which is believed to lessen pain by increasing endogenous opioid activity.
    Physiology & Behavior 10/2013; · 3.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effects of intraperitoneal (ip) d-glucose administration on antinociception were studied in male Long-Evans rats. Rats were assessed for antinociception using the hot-water tail-withdrawal procedure (54±0.2° C) to determine if peripheral administration of d-glucose (300, 560, or 720mg/kg) would enhance morphine-mediated antinociception (MMA) (1.0, 3.0, 4.2, 5.6, and 10.0mg/kg cumulative-dosing regime) and if d-glucose (560, 720, or 1000mg/kg) alone could produce antinociceptive activity that was naloxone (0.32mg/kg) reversible. Additionally, the actions of d-glucose on MMA were compared with a stereoisomer, l-glucose, which is not metabolized. The results of these studies demonstrate that peripheral administration of d-glucose significantly enhances MMA and that d-glucose alone produces antinociceptive actions that are potentially mediated by the endogenous opioid system. Furthermore, l-glucose failed to have an effect on MMA suggesting that the alterations in antinociception seen with d-glucose are not due to stressors such as osmolality or injection. The current studies provide evidence that d-glucose alteration of antinociception is not simply a response to taste or gustation.
    Pharmacology Biochemistry and Behavior 12/2013; · 2.82 Impact Factor